Skip to content
Research Article Open access CC BY 4.0

Therapeutic Prospects of Mulberry-Derived DNJ: A Review

Tejaswini A S, Kaveri Aramani, Veenita M K, Nikita Kankanawadi, Gagana Sindhu S, Basanagouda Jekinakatti

Journal of Advances in Biology & Biotechnology · pp. 292–308 · Published 30 Jul 2025

10.9734/jabb/2025/v28i82706

Abstract

Deoxynojirimycin (DNJ) is a naturally occurring iminosugar primarily found in mulberry (Morus spp.) leaves and is known for its potent α-glucosidase inhibitory activity. Due to this property, DNJ plays a significant role in regulating blood glucose levels, making it a promising natural compound for the management of type 2 diabetes. Beyond its antidiabetic effects, DNJ exhibits potential in combating obesity and improving lipid metabolism. It also shows antiviral, antimicrobial, and hepatoprotective activities, expanding its therapeutic relevance. The extraction and purification of DNJ from mulberry have been optimized to enhance its yield and bioavailability. Overall, DNJ from mulberry presents a valuable bioactive compound with diverse applications in pharmaceuticals and functional foods.

1-Deoxynojirimycin mulberry plant anti-diabetic agent natural compound

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

4

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.